Zynerba Pharmaceuticals Inc. (ZYNE) reported a fourth quarter loss of $0.62 per share Monday morning, compared to the loss of $0.96 per share last year. The consensus estimate was for a loss of $0.29 per share.
from RTT - Before the Bell http://ift.tt/251G950
via IFTTT
No comments:
Post a Comment